Zhanjun Zhang

Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study

Longfei Jia, Yifeng Du, Lan Chu et al. · The Lancet Public Health · 2020 · 1.7K citations · Full text

Medicine, Geriatric Medicine, Neurology +17

Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China

Shenjie Tang, Lan Yao, Xiaohui Hao et al. · European Respiratory Journal · 2014 · 177 citations

Medicine, Pharmacology, Pharmacotherapy +13

Clofazimine for the Treatment of Multidrug-Resistant Tuberculosis: Prospective, Multicenter, Randomized Controlled Study in China

Shenjie Tang, Lan Yao, Xiaohui Hao et al. · Clinical Infectious Diseases · 2015 · 147 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Risk Factors for Poor Treatment Outcomes in Patients with MDR-TB and XDR-TB in China: Retrospective Multi-Center Investigation

Shenjie Tang, Shouyong Tan, Lan Yao et al. · PLoS ONE · 2013 · 128 citations · Full text

Public Health, Infectious Diseases, Internal Medicine +16

The positive impacts of early-life education on cognition, leisure activity, and brain structure in healthy aging

Yaojing Chen, Chen‐Long Lv, Xin Li et al. · Aging · 2019 · 119 citations · Full text

Education, Neuroscience, Psychology +17